Trial NCT00554775

View at ClinicalTrials.gov 
Org. Study IDs: CDR0000573254
Secondary IDs: 2006-000113-38 BRD/05/177 CRUK-TACTIC CRUK-UCL-BRD-05-177 EU-20792 ISRCTN31916843

Last trial update was posted on 2011-12-12

MeSH Interventions

Erlotinib Hydrochloride

MeSH Conditions

Brain Neoplasms Lung Neoplasms

Other Conditions

Lung Cancer Metastatic Cancer

Stopping Reasons

IDMC made a recommendation to stop the trial as the target for continuing to the 2nd phase was not met.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID